Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NaturaLens is a medical device company specializing in the design and manufacture of specialty contact lenses, with a particular focus on orthokeratology (ortho-k). The company provides advanced vision correction solutions, including the NaturaLens Ortho-K system, which is designed to reshape the cornea overnight to provide clear vision during the day without the need for glasses or daytime contacts. In 2021, NaturaLens was acquired by Euclid Vision Group, a leader in advanced orthokeratology and proactive myopia management. The company's products are used by eye care professionals to manage myopia and other refractive errors in both children and adults. NaturaLens is recognized for its innovative lens designs and its contribution to the field of corneal refractive therapy. The acquisition by Euclid has integrated NaturaLens's technology into a broader portfolio of myopia management solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NaturaLens.